The biochemical effect of a nicotinamide analogue, 6-aminonicotinamide (6-AN), on developing chick embryonic femur was studied. Growth of femur from 9-day-old embryos that had been exposed to 6-AN for 5 days in ovo was not stimulated by PTH in an in vitro culture system. PTH caused a much smaller increase in the cyclic-AMP content in 6-AN-treated femur than in control femur. However, dibutyryl cyclic-AMP stimulated growth of 6-AN-treated femur. A defect in response of 6-AN-treated femur to the growth stimulating action of PTH may explain the production of micromelia by 6-AN.
The nicotinamide analogue 6-aminonicotinamide (6-AN) has a teratogenic effect on developing chick embryos in ovo, causing micromelia (Landauer, 1957; Caplan, 1971 Caplan, , 1972a Seegmiller et al., 1972; Seegmiller, 1977; McLachlan, 1980) . These in ovo experiments have been extended to in vitro culture systems (Caplan, 1972a, b; Schubert and Lacorbiere, 1976) . Several investigators have proposed that this teratogen alters the developmental pathway of the mesodermal cells to chondrocytes or myogenic cells (Landauer, 1957; Caplan, 1972a, b; Schubert and Lacorbiere, 1976) . However, this explanation of the teratogenic effect of 6-AN seems incorrect since 6-AN is still effective on 8-day-old chick embryos (McLachlan, J. C., 1980) in which the chondrogenic and myogenic tissues are already physically separated (Hamberger and Hamilton, 1951) . Probably 6-AN affects chondrocyte growth and/or terminal differentiation rather than causing a switch in the pathway of development of mesodermal cells.
We previously demonstrated that parathyroid hormone (PTH) stimulates the growth of isolated femur from 9-day-old chick embryos in an in vitro culture system by causing a rise in the cyclic-AMP level (Kawashima et al., 1980a, b) . In the present work we tested whether 6-AN-treated femur showed a growth response with PTH.
Results showed that exposure to 6-AN in ovo resulted in loss of response of isolated femur to PTH in vitro. 
